Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology.

Literature DB >> 28970294

The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology.

Richard A Baylis¹, Delphine Gomez¹, Ziad Mallat¹, Gerard Pasterkamp¹, Gary K Owens².

Abstract

Entities: Chemical Disease Gene Species

Keywords: atherosclerosis; coronary artery disease; inflammation; interleukins; translational medical research

Mesh：

Substances：

Year: 2017 PMID： 28970294 PMCID： PMC5685554 DOI： 10.1161/ATVBAHA.117.310097

Source DB: PubMed Journal: Arterioscler Thromb Vasc Biol ISSN： 1079-5642 Impact factor: 8.311

× No keyword cloud information.

25 in total

Review 1. Macrophages in atherosclerosis: a dynamic balance.

Authors: Kathryn J Moore; Frederick J Sheedy; Edward A Fisher
Journal: Nat Rev Immunol Date: 2013-09-02 Impact factor: 53.106

Review 2. Inflammation in atherosclerosis.

Authors: Peter Libby
Journal: Arterioscler Thromb Vasc Biol Date: 2012-09 Impact factor: 8.311

3. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.

Authors: José J Fuster; Susan MacLauchlan; María A Zuriaga; Maya N Polackal; Allison C Ostriker; Raja Chakraborty; Chia-Ling Wu; Soichi Sano; Sujatha Muralidharan; Cristina Rius; Jacqueline Vuong; Sophia Jacob; Varsha Muralidhar; Avril A B Robertson; Matthew A Cooper; Vicente Andrés; Karen K Hirschi; Kathleen A Martin; Kenneth Walsh
Journal: Science Date: 2017-01-19 Impact factor: 47.728

4. How Common Is Residual Inflammatory Risk?

Authors: Paul M Ridker
Journal: Circ Res Date: 2017-02-17 Impact factor: 17.367

5. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors: Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal: N Engl J Med Date: 2017-08-27 Impact factor: 91.245

6. Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction.

Authors: Hendrik B Sager; Timo Heidt; Maarten Hulsmans; Partha Dutta; Gabriel Courties; Matthew Sebas; Gregory R Wojtkiewicz; Benoit Tricot; Yoshiko Iwamoto; Yuan Sun; Ralph Weissleder; Peter Libby; Filip K Swirski; Matthias Nahrendorf
Journal: Circulation Date: 2015-09-10 Impact factor: 29.690

Review 7. Macrophage death and defective inflammation resolution in atherosclerosis.

Authors: Ira Tabas
Journal: Nat Rev Immunol Date: 2009-12-04 Impact factor: 53.106

8. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.

Authors: Paul M Ridker; Jean G MacFadyen; Tom Thuren; Brendan M Everett; Peter Libby; Robert J Glynn
Journal: Lancet Date: 2017-08-27 Impact factor: 79.321

Review 9. The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications.

Authors: Christian Herder; Elise Dalmas; Marianne Böni-Schnetzler; Marc Y Donath
Journal: Trends Endocrinol Metab Date: 2015-10 Impact factor: 12.015

10. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis.

Authors: Laura S Shankman; Delphine Gomez; Olga A Cherepanova; Morgan Salmon; Gabriel F Alencar; Ryan M Haskins; Pamela Swiatlowska; Alexandra A C Newman; Elizabeth S Greene; Adam C Straub; Brant Isakson; Gwendalyn J Randolph; Gary K Owens
Journal: Nat Med Date: 2015-05-18 Impact factor: 53.440

25 in total

1. Complement Membrane Attack Complexes Assemble NLRP3 Inflammasomes Triggering IL-1 Activation of IFN-γ-Primed Human Endothelium.

Authors: Catherine B Xie; Lingfeng Qin; Guangxin Li; Caodi Fang; Nancy C Kirkiles-Smith; George Tellides; Jordan S Pober; Dan Jane-Wit
Journal: Circ Res Date: 2019-04-22 Impact factor: 17.367

Review 2. Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

Authors: Paul M Ridker
Journal: Circ Res Date: 2019-02 Impact factor: 17.367

Review 3. Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.

Authors: José J Fuster; Kenneth Walsh
Journal: Circ Res Date: 2018-02-02 Impact factor: 17.367

Review 4. Clinical imaging of cardiovascular inflammation.

Authors: Claudia Calcagno; Zahi A Fayad
Journal: Q J Nucl Med Mol Imaging Date: 2020-02-18 Impact factor: 2.346

Review 5. Vascular Endothelial Cells and Innate Immunity.

Authors: Ying Shao; Jason Saredy; William Y Yang; Yu Sun; Yifan Lu; Fatma Saaoud; Charles Drummer; Candice Johnson; Keman Xu; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal: Arterioscler Thromb Vasc Biol Date: 2020-05-27 Impact factor: 8.311

6. The small molecule Chicago Sky Blue promotes heart repair following myocardial infarction in mice.

Authors: Oren Yifa; Karen Weisinger; Elad Bassat; Hanjun Li; David Kain; Haim Barr; Noga Kozer; Alexander Genzelinakh; Dana Rajchman; Tamar Eigler; Kfir Baruch Umansky; Daria Lendengolts; Ori Brener; Nenad Bursac; Eldad Tzahor
Journal: JCI Insight Date: 2019-11-14